Protection Because of Prior SARS-CoV-2 Infection | Infectious Diseases | JN Learning | AMA Ed Hub [Skip to Content]
Outline
Claim CME
PDF
Infectious Diseases

Protection Because of Prior SARS-CoV-2 Infection

Educational Objective
To identify the key insights or developments described in this article
1 Credit CME
JAMA Internal Medicine
October 1, 2021
Editor's Note
Mitchell H. Katz, MD1
Author Affiliations
  • 1NYC Health and Hospitals, New York, New York
Read article on JAMA Network

MOC/CME Information

editorial comment icon
Editorial
Comment
 related articles icon
Related
Articles
 author interview icon
Interviews
 multimedia icon
Multimedia
Read Article Claim CME

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Related Articles

  1. Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy
    1.00 CME

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

See More About

Infectious Diseases Coronavirus (COVID-19)
Article Information

Published Online: May 28, 2021. doi:10.1001/jamainternmed.2021.2966

Corresponding Author: Mitchell H. Katz, MD, NYC Health and Hospitals, 125 Worth St, Room 514, New York, NY 10013 (mitchell.katz@nychhc.org).

Conflict of Interest Disclosures: None reported.

References
1.
Vitale  J , Mumoli  N , Clerici  P ,  et al.  Assessment of SARS-CoV-2 reinfection 1 year after primary infection in a population in Lombardy, Italy.   JAMA Intern Med. Published online May 28, 2021. doi:10.1001/jamainternmed.2021.2959Google Scholar
2.
Harvey  RA , Rassen  JA , Kabelac  CA ,  et al.  Association of SARS-CoV-2 seropositive antibody test with risk of future infection.   JAMA Intern Med. 2021;181(5):672-679. doi:10.1001/jamainternmed.2021.0366PubMedGoogle ScholarCrossref
3.
Spellberg  B , Nielsen  TB , Casadevall  A .  Antibodies, immunity, and COVID-19.   JAMA Intern Med. 2021;181(4):460-462. doi:10.1001/jamainternmed.2020.7986PubMedGoogle ScholarCrossref
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Privacy Policy|Terms of Use
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue